Business Wire

Envision the Future of Autonomous Solutions with Velodyne Lidar at CES 2022

Share

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) will demonstrate its revolutionary lidar sensors and software at CES 2022 in the Las Vegas Convention Center Tech East, West Hall – booth #6005. Velodyne will highlight how its lidar technology powers autonomous solutions that bring safety, sustainability, efficiency and privacy benefits.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211214005449/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

At CES 2022, Velodyne Lidar will demonstrate its revolutionary lidar sensors and software which power autonomous solutions that bring safety, sustainability, efficiency and privacy benefits. (Photo: Velodyne Lidar)

Velodyne will host an in-booth press conference, featuring CEO Dr. Ted Tewksbury, on January 5 at 11:45 a.m. PST. Velodyne will showcase how it is the only lidar company today, through its cutting-edge hardware and software solutions, that can provide a full circle of autonomy and safety across of a wide range of markets, including automotive, industrial, infrastructure and robotics.

“CES attendees can see Velodyne’s broad sensor and software portfolio and high-performing lidar technology. We are demonstrating how our lidar-based autonomous technology is shaping the future of the automotive, industrial and robotics sectors and helping create sustainable and efficient infrastructure. With our ability to manufacture at scale, we are positioned to capitalize on the first wave of mass commercialization of lidar solutions,” said Dr. Tewksbury.

Trailblazing Lidar Sensors and Software

At the Velodyne booth, exhibitors, customers and industry partners will have the opportunity to hear from Velodyne’s executives and technical experts about how the company’s sensors and software democratize lidar-based safety and autonomy. Among the products Velodyne will showcase are:

  • The Alpha Prime is the optimal long-range sensor for autonomous mobility. The Alpha Prime’s world-class combination of range, image clarity and field of view detects roadway objects with reliability and precision. This state-of-the-art sensor generates a high-quality point cloud in a wide variety of light conditions, with advanced sensor-to-sensor interference mitigation, power efficiency and thermal performance.
  • Velodyne‘s solid-state Velarray H800 is a lidar sensor architected for automotive-grade performance. The sensor is built using Velodyne’s breakthrough proprietary micro-lidar array (MLA) architecture. With combined long-range perception and a broad field of view, the Velarray H800 is designed for safe navigation and collision avoidance in advanced driver assistance systems (ADAS) and autonomous mobility applications to achieve advanced driver assistance.
  • Velarray M1600, built with Velodyne’s MLA, provides excellent near-field perception for safe navigation, enabling touch-free movement and last-mile delivery robots to operate autonomously and safely without human intervention. This durable and compact sensor can be deployed in various environments and weather conditions and can be used in almost all weather throughout the year. Velodyne will feature a live Extended Reality (XR) demonstration of Velarray M1600 sensors.
  • Velodyne’s Intelligent Infrastructure Solution (IIS), which creates a real-time 3D map of roads and intersections, provides precise traffic monitoring and analytics that is not possible with other types of sensors such as cameras or radar. IIS reliably collects data in any lighting or weather condition, supporting year-round operation, while also protecting people's privacy. The solution can predict, diagnose and address road safety challenges, helping municipalities and other customers make informed decisions to take corrective action.
  • The Vella Development Kit (VDK) simplifies building autonomous solutions. VDK provides access to Velodyne’s breakthrough Vella perception software paired with its world-class lidar sensors. The software toolkit allows customers to plug in lidar with an off-the-shelf library of functions. VDK advances solution development and accelerates time to market for bringing lidar capabilities to autonomous vehicles, ADAS, mobile delivery devices, industrial robotics, drones and more.

Autonomous Solutions That Are Transforming Industries

The booth will feature products and presentations from customers and partners that are using Velodyne’s lidar technology in a range of transformative solutions including automotive, logistics, mapping, robotics, traffic monitoring, vegetation management and more. The autonomous solution demonstrations are:

Bluecity solutions facilitate the improvement of road safety and mobility in the road networks by providing real-time traffic data and analytics using innovative technology. The company developed AI-powered software integrated with Velodyne’s lidar sensors to monitor traffic networks, generate real-time traffic data and analytics. Bluecity will be showcasing their AI technology at Velodyne’s Intelligent Infrastructure Solution (IIS) demo in the booth.

EasyMile driverless technology is at the core of award-winning solutions for mobility, intralogistics and more. At the Velodyne booth will be TractEasy, the company’s tow-truck autonomous solution that optimizes supply chains with cross/indoor-outdoor, 24/7 material handling at airports, factories and industrial sites.

Emesent is a leader in lidar-based drone autonomy and mapping, with a focus on underground mining and industrial asset inspection. The company’s Hovermap product is a versatile and intelligent lidar scanner that makes mapping of inaccessible areas safe, easy and fast. The Hovermap will be integrated with a Boston Dynamics Spot robot at the Velodyne booth.

Exyn Technologies has pioneered autonomous aerial robot systems for complex, GPS-denied environments. The company’s full-stack solution enables flexible deployment of single or multiple robots that can intelligently navigate and dynamically adapt to complex environments in real time. Exyn will introduce a new pilotless drone designed for autonomous flight in high-risk environments and will be demonstrating their solution at the Velodyne booth.

MOBILTECH provides a 3D spatial information service that uses mapping, localization, perception and sensor fusion technologies. The company offers a portfolio of 3D mapping scanners, which include Velodyne’s lidar sensors, that can be deployed in vehicle, handheld and unmanned aerial vehicle (UAV) mode. MOBILTECH will offer a presentation at the Velodyne booth during the conference.

Navya will demonstrate its Autonom Shuttle, a revolutionary first and last mile travel solution. Autonomous, electric and shared, the shuttle serves cities and private sites around the world by providing ever more fluid mobility. With neither a steering wheel nor pedals, Autonom Shuttle is at the cutting edge of multi-sensor technology, including Velodyne’s lidar, which allows it to interact in real time with its environment.

Renu Robotics is an industry leader in autonomous vegetation management systems. The company’s Renubot is a fully autonomous, all-electric mower that helps solar and energy facilities cut costs, time and carbon emissions, while maintaining the grounds for maximum performance of the facility. A Renubot will be on display at the Velodyne booth.

Roborace will demonstrate its DevBot 2.0, an all-electric, autonomous vehicle that includes Velodyne’s lidar sensors. Roborace is the world’s first competition for human + machine teams to test the development of their automated driving systems.

The Boston Dynamics Spot mobile robot can navigate terrain with unprecedented mobility, allowing companies to automate routine inspection tasks and data capture safely, accurately and frequently. At CES, Velodyne will demonstrate Spot integrated with Emesent’s Hovermap lidar scanner.

Twinny develops and manufactures indoor AI autonomous driving robots. Twinny’s product family includes NarGo, a fully autonomous freight robot that carries heavy goods while following a person in a retail or warehouse environment. It also includes NarGo Follower, a freight robot that follows NarGo, providing additional freight-moving capacity. Twinny will offer a presentation at the Velodyne booth during the conference.

How Lidar Solutions Can Advance Transportation Equity

At the CES conference, Christina Aizcorbe, Velodyne’s Vice President of Government Affairs, will speak on a panel that will explore how transportation technologies are a key driver to increase safety, accessibility and mobility for all travelers. Ms. Aizcorbe will discuss how lidar-based transportation solutions can advance accessibility efforts and also support safety, sustainability and efficiency. The session, called “Leveraging Technology for Transportation Equity,” takes place on January 6 at 11:00 a.m. PST at LVCC, West Level 2, W213-215.

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne, the global leader in lidar, is known for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com .

Forward Looking Statements

This press release contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, and competition. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," “can,” "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include uncertainties regarding government regulation and adoption of lidar, the uncertain impact of the COVID-19 pandemic on Velodyne's and its customers' businesses; Velodyne's ability to manage growth; Velodyne's ability to execute its business plan; uncertainties related to the ability of Velodyne's customers to commercialize their products and the ultimate market acceptance of these products; the rate and degree of market acceptance of Velodyne's products; the success of other competing lidar and sensor-related products and services that exist or may become available; uncertainties related to Velodyne's current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne's intellectual property; and general economic and market conditions impacting demand for Velodyne's products and services. For more information about risks and uncertainties associated with Velodyne’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Velodyne’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. All forward-looking statements in this press release are based on information available to Velodyne as of the date hereof, Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Velodyne Investor Relations
InvestorRelations@velodyne.com

Velodyne Media
Codeword
Liv Allen
velodyne@codewordagency.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye